-
公开(公告)号：US20050164294A1
公开(公告)日：2005-07-28
申请号：US11090866
申请日：2005-03-25
申请人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
IPC分类号： A61K38/00 , C12N9/64 , H01Q1/36 , H01Q1/38 , H01Q3/44 , H01Q5/00 , H01Q9/04 , H01Q15/02 , C12Q1/68 , C07H21/04
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw-) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
摘要翻译： 公开了各种形式的纯化和重组形式的活性，分离的β-分泌酶。 这种酶涉及积聚在患有阿尔茨海默病的个体的脑中的淀粉样蛋白斑块成分的产生。 也公开了单独或与其一些天然底物（β-APPwt和β-APPsw-）组合产生该酶的重组细胞，以及针对这种蛋白质的抗体。 这些组合物可用于选择调节β-分泌酶的化合物的方法。 β-分泌酶的抑制剂涉及作为治疗神经变性疾病如阿尔茨海默病的治疗剂。
-
公开(公告)号：US20050177888A1
公开(公告)日：2005-08-11
申请号：US11090872
申请日：2005-03-25
申请人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
IPC分类号： A61K38/00 , C12N9/64 , H01Q1/36 , H01Q1/38 , H01Q3/44 , H01Q5/00 , H01Q9/04 , H01Q15/02 , C12Q1/68 , A01K67/027 , C07H21/04 , G01N33/53 , G01N33/567
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
-
公开(公告)号：US20050196839A1
公开(公告)日：2005-09-08
申请号：US11090399
申请日：2005-03-25
申请人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
IPC分类号： A61K38/00 , C12N9/64 , H01Q1/36 , H01Q1/38 , H01Q3/44 , H01Q5/00 , H01Q9/04 , H01Q15/02 , C07H21/04
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
-
公开(公告)号：US20050170489A1
公开(公告)日：2005-08-04
申请号：US11069377
申请日：2005-02-28
申请人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
摘要翻译： 公开了各种形式的纯化和重组形式的活性，分离的β-分泌酶。 这种酶涉及积聚在患有阿尔茨海默病的个体的脑中的淀粉样蛋白斑块成分的产生。 产生该酶的重组细胞单独或与其一些天然底物（β-APPwt和β-APPsw）组合也被公开，以及针对这种蛋白质的抗体。 这些组合物可用于选择调节β-分泌酶的化合物的方法。 β-分泌酶的抑制剂涉及作为治疗神经变性疾病如阿尔茨海默病的治疗剂。
-
公开(公告)号：US20050164327A1
公开(公告)日：2005-07-28
申请号：US11089918
申请日：2005-03-25
申请人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
IPC分类号： A61K38/00 , C12N9/64 , H01Q1/36 , H01Q1/38 , H01Q3/44 , H01Q5/00 , H01Q9/04 , H01Q15/02 , C12Q1/37
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
-
公开(公告)号：US07262043B2
公开(公告)日：2007-08-28
申请号：US11090399
申请日：2005-03-25
申请人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
摘要翻译： 公开了各种形式的纯化和重组形式的活性，分离的β-分泌酶。 这种酶涉及积聚在患有阿尔茨海默病的个体的脑中的淀粉样蛋白斑块成分的产生。 产生该酶的重组细胞单独或与其一些天然底物（β-APPwt和β-APPsw）组合也被公开，以及针对这种蛋白质的抗体。 这些组合物可用于选择调节β-分泌酶的化合物的方法。 β-分泌酶的抑制剂涉及作为治疗神经变性疾病如阿尔茨海默病的治疗剂。
-
公开(公告)号：US07276349B2
公开(公告)日：2007-10-02
申请号：US11090872
申请日：2005-03-25
申请人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
摘要翻译： 公开了各种形式的纯化和重组形式的活性，分离的β-分泌酶。 这种酶涉及积聚在患有阿尔茨海默病的个体的脑中的淀粉样蛋白斑块成分的产生。 产生该酶的重组细胞单独或与其一些天然底物（β-APPwt和β-APPsw）组合也被公开，以及针对这种蛋白质的抗体。 这些组合物可用于选择调节β-分泌酶的化合物的方法。 β-分泌酶的抑制剂涉及作为治疗神经变性疾病如阿尔茨海默病的治疗剂。
-
公开(公告)号：US07115410B1
公开(公告)日：2006-10-03
申请号：US09723722
申请日：2000-11-28
申请人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
摘要翻译： 公开了各种形式的纯化和重组形式的活性，分离的β-分泌酶。 这种酶涉及积累在患有阿尔茨海默氏病的个体的脑中的淀粉样蛋白斑块成分的生成重组细胞单独或与其一些天然底物（β-APPwt和β-APPsw）组合产生该酶的重组细胞也是 公开的是针对这种蛋白质的抗体。 这些组合物可用于选择调节β-分泌酶的化合物的方法。 β-分泌酶的抑制剂涉及作为治疗神经变性疾病如阿尔茨海默病的治疗剂。
-
公开(公告)号：US20090144840A1
公开(公告)日：2009-06-04
申请号：US12191950
申请日：2008-08-14
申请人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
IPC分类号： G01N33/573 , A01K67/027
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
摘要翻译： 公开了各种形式的纯化和重组形式的活性，分离的β-分泌酶。 这种酶涉及积聚在患有阿尔茨海默病的个体的脑中的淀粉样蛋白斑块成分的产生。 产生该酶的重组细胞单独或与其一些天然底物（β-APPwt和β-APPsw）组合也被公开，以及针对这种蛋白质的抗体。 这些组合物可用于选择调节β-分泌酶的化合物的方法。 β-分泌酶的抑制剂涉及作为治疗神经变性疾病如阿尔茨海默病的治疗剂。
-
公开(公告)号：US07252963B2
公开(公告)日：2007-08-07
申请号：US11090866
申请日：2005-03-25
申请人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
-
-
-
-
-
-
-
-
-
搜索结果
17 条记录 (耗时 0.046 秒)
